Investigational Therapy Appears to Prevent Neuron Death, Improve Huntington’s Symptoms in Mice
A drug in clinical development by Takeda for schizophrenia, called TAK-063, was seen to reduce neuron death and improve symptoms in mice with Huntington’s disease. But the data needs to be confirmed in other animal models of Huntington’s, and it is too early to say if the drug would also benefit…